IceCure Medical (ICCM) EBT Margin (2025 - 2026)
IceCure Medical (ICCM) reported EBT Margin of 466.19% for Q1 2026, down 3822.0% year-over-year from 12.53% in Q1 2025, and down 7.58% on a QoQ basis from 504.41% in Q1 2025.
IceCure Medical (ICCM) has 2 years of EBT Margin data on file, last reported at 466.19% in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.17% |
| 10 | IceCure Medical | 12.09 | -8.11 Mn | 295,000.00 | 466.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 466.19% |
| Mar 31, 2025 | 504.41% |